These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 10846517)
21. Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index. Chlebowski RT; Anderson GL; Aragaki AK; Prentice R J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26546117 [TBL] [Abstract][Full Text] [Related]
22. Hormonal therapy and risk of breast cancer in mexican women. Amadou A; Fabre A; Torres-Mejía G; Ortega-Olvera C; Angeles-Llerenas A; McKenzie F; Biessy C; Hainaut P; Romieu I PLoS One; 2013; 8(11):e79695. PubMed ID: 24260282 [TBL] [Abstract][Full Text] [Related]
23. Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Phillips LS; Millikan RC; Schroeder JC; Barnholtz-Sloan JS; Levine BJ Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1507-14. PubMed ID: 19423528 [TBL] [Abstract][Full Text] [Related]
24. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757 [TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives and the risk of breast cancer. Marchbanks PA; McDonald JA; Wilson HG; Folger SG; Mandel MG; Daling JR; Bernstein L; Malone KE; Ursin G; Strom BL; Norman SA; Wingo PA; Burkman RT; Berlin JA; Simon MS; Spirtas R; Weiss LK N Engl J Med; 2002 Jun; 346(26):2025-32. PubMed ID: 12087137 [TBL] [Abstract][Full Text] [Related]
26. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies. Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589 [TBL] [Abstract][Full Text] [Related]
27. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715 [TBL] [Abstract][Full Text] [Related]
28. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Jick SS; Hagberg KW; Kaye JA; Jick H Obstet Gynecol; 2009 Jan; 113(1):74-80. PubMed ID: 19104362 [TBL] [Abstract][Full Text] [Related]
29. Race, anthropometric factors, and stage at diagnosis of breast cancer. Moorman PG; Jones BA; Millikan RC; Hall IJ; Newman B Am J Epidemiol; 2001 Feb; 153(3):284-91. PubMed ID: 11157416 [TBL] [Abstract][Full Text] [Related]
30. Menstrual factors in relation to breast cancer risk. Titus-Ernstoff L; Longnecker MP; Newcomb PA; Dain B; Greenberg ER; Mittendorf R; Stampfer M; Willett W Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):783-9. PubMed ID: 9752986 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation. Conway K; Parrish E; Edmiston SN; Tolbert D; Tse CK; Moorman P; Newman B; Millikan RC Breast Cancer Res; 2007; 9(3):R36. PubMed ID: 17553133 [TBL] [Abstract][Full Text] [Related]
32. Birthweight, parental age, birth order and breast cancer risk in African-American and white women: a population-based case-control study. Hodgson ME; Newman B; Millikan RC Breast Cancer Res; 2004; 6(6):R656-67. PubMed ID: 15535848 [TBL] [Abstract][Full Text] [Related]
33. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study. Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159 [TBL] [Abstract][Full Text] [Related]
34. Active smoking and risk of Luminal and Basal-like breast cancer subtypes in the Carolina Breast Cancer Study. Butler EN; Tse CK; Bell ME; Conway K; Olshan AF; Troester MA Cancer Causes Control; 2016 Jun; 27(6):775-86. PubMed ID: 27153846 [TBL] [Abstract][Full Text] [Related]
35. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762 [TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of breast cancer risk factors among African-American women and White women. Hall IJ; Moorman PG; Millikan RC; Newman B Am J Epidemiol; 2005 Jan; 161(1):40-51. PubMed ID: 15615914 [TBL] [Abstract][Full Text] [Related]
37. Physical activity and breast cancer risk among women in the southwestern United States. Slattery ML; Edwards S; Murtaugh MA; Sweeney C; Herrick J; Byers T; Giuliano AR; Baumgartner KB Ann Epidemiol; 2007 May; 17(5):342-53. PubMed ID: 17462544 [TBL] [Abstract][Full Text] [Related]
38. Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France. Cordina-Duverger E; Truong T; Anger A; Sanchez M; Arveux P; Kerbrat P; Guénel P PLoS One; 2013; 8(11):e78016. PubMed ID: 24223752 [TBL] [Abstract][Full Text] [Related]
39. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study. Palmer JR; Rosenberg L; Clarke EA; Miller DR; Shapiro S Am J Epidemiol; 1991 Dec; 134(12):1386-95; discussion 1396-401. PubMed ID: 1663701 [TBL] [Abstract][Full Text] [Related]